U.S. Finalizes $1B CHIPS Act Award for IBM’s Anderon Quantum Foundry to Scale Domestic Wafer Manufacturing
Originally published as: U.S. Awards Anderon $1B for Quantum Wafer Manufacturing
AI overview
The establishment of a dedicated domestic quantum foundry provides hardware teams with a scalable path for commercializing superconducting qubits and readout electronics.
Anderon, an IBM company operating as a dedicated quantum foundry in Albany, New York, has officially finalized a $1 billion funding agreement under the U.S. CHIPS and Science Act. Backed by an additional $1 billion co-investment from IBM, the initiative aims to transition quantum processors from academic and pre-production research to high-yield commercial manufacturing.
The facility is structured as a pure-play 300-millimeter wafer fab, focusing initially on superconducting qubit arrays, quantum input/output signaling, and readout signal chain components. By establishing a dedicated domestic source for these specialized devices, the project addresses core bottlenecks in quantum scaling, reducing reliance on ad-hoc classical semiconductor lines adapted for quantum use.
Hardware design teams working on quantum or cryogenic systems should monitor Anderon's rollout of process design kits (PDKs) and multi-project wafer offerings. As the foundry expands beyond superconducting architectures into silicon photonics and spin qubits, it will shape standard packaging and integration pathways for next-generation compute hardware.
Questions & answers
Anderon operates as a 300-millimeter pure-play quantum wafer foundry focusing on superconducting qubit arrays, quantum I/O signaling, and readout signal chain components.
